No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Bone Density Conservation Agents / adverse effects*
-
Bone Neoplasms / drug therapy
-
Bone Neoplasms / secondary
-
Denosumab
-
Diphosphonates / adverse effects*
-
Humans
-
Imidazoles / adverse effects*
-
Incidence
-
Jaw Diseases / chemically induced*
-
Osteonecrosis / chemically induced*
-
Osteonecrosis / epidemiology
-
RANK Ligand / adverse effects*
-
Zoledronic Acid
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bone Density Conservation Agents
-
Diphosphonates
-
Imidazoles
-
RANK Ligand
-
Denosumab
-
Zoledronic Acid